Login
$WKHS
$2.56 +$0.02 (0.79%) Live

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, less allowance for credit losses of $168 and $435 as of June 30, 2026 and December 31, 2025, respectively
Other receivables, net
Inventory, net
Prepaid expenses and other current assets
Other current assets
Total current assets
Property, plant and equipment, net
Investment in Tropos
Lease right-of-use assets
Goodwill
Intangible assets, net
Operating lease right-of-use assets, net
Finance lease right-of-use assets, net
Other assets
Total Assets
Liabilities
Current liabilities:
Accounts payable
Accrued liabilities and other current liabilities
Deferred revenue
Warranty liability - current portion
Current portion of lease liabilities
Operating lease liability - current portion
Finance lease liability - current portion
Warrant liability
Warrant liability at fair value
Convertible notes at fair value
Stock rights liability
Senior secured promissory note - related party
Customer order credit agreement - related party
Total current liabilities
Deferred revenue, long-term
Lease liabilities, long-term
Convertible note at fair value - long-term
Operating lease liability - long-term
Financing lease liability - long-term
Cash flow credit agreement - related party
Convertible notes at fair value - related party
Related Party
Other long-term liabilities
Warranty liability - long-term
Total Liabilities
Stockholders’ Equity:
Series A preferred stock, par value of $0.001 per share, 75,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Common stock, par value $0.001 per share, 36,000,000 shares authorized, 10,893,417 and 9,699,858 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support